Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis selectively by activating death receptor 4 or 5 (DR4/5) in a wide range of cancers while sparing normal cells [5–7]. Here, TNFSF10 is linked to cancer.